Skip to main content

Table 2 Summary of results of recent series on stereotactic radiosurgery for GH-secreting pituitary adenomas

From: Radiation techniques for acromegaly

Authors

patients

type of

total dose

follow-up

tumor

biochemical remission

late toxicity (%)

  

SRS

(Gy)

median (months)

control (%)

(%)

visual

hypopituitarism

Attanasio et al., 2003 [34]

30

GK SRS

20

46

100

30 at 5 years

0

6.7

Jane et al., 2003 [35]

64

GK SRS

15

> 18

NA

36

0

28

Castinetti et al., 2005 [36]

82

GK SRS

26

49.5*

NA

17

1.2

17

Gutt et al., 2005 [37]

44

GK SRS

23

22

100

48

NA

NA

Kobayashi et al., 2005 [38]

67

GK SRS

18,9

63

100

17

11

15

Jezkova et al., 2006 [39]

96

GK SRS

32

53.7

100

44 at 5 years

0

27.1

Voges et al., 2006 [40]

64

LINAC SRS

16,5

54.3

97

14 and 33 at 3 and 5 years

1.4

13 and 18 at 3 and 5 years

Petit et al., 2007 [32]

22

PSRS

20 GyE

75.6

100

59

0

38

Pollock et al., 2007 [41]

46

GK SRS

20

63

100

11 and 60 at 2 and 5 years

0

33 at 5 years

Vik-Mo et al., 2007 [42]

53

GK SRS

26.5

67

100

58 and 86 at 5 and 10 years

3.8

10 at 5 years

Jagannathan et al., 2008 [43]

95

GK SRS

22

57

98

53

4

34

Losa et al., 2008 [44]

83

GK SRS

21,5

69

97

52 and 85 at 5 and 10 years

0

10 at 10 years

Ronchi et al., 2009 [45]

35

GK SRS

20

114

100

46 at 10 years

0

50

Wan et al., 2009 [46]

103

GK SRS

21,4

67

95

37

0

6

Hayashi et al., 2010 [47]

25

GK SRS

25.2

36

100

40

0

0

Iwai et al., 2010 [48]

26

GK SRS

20

84

96

17 and 47 at 5 and 10 years

0

8

  1. *mean follow-up; NA not assessed.
  2. SRS, stereotactic radiosurgery; GKS, Gamma Knife radiosurgery.
  3. PSRS; proton stereotactic radiosurgery.